Scripps Tumorgraft Study

Scripps Translational Science Institute11 enrolled

Overview

Study the genetic traits of cancerous tissues and to help improve cancer treatment by developing tumor models for studying new cancer drugs.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Solid Tumor Malignancy or Hematologic Malignancy

Eligibility

Sex: ALLMin age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 21 or over * diagnosis of a solid tumor malignancy, either resectable or metastatic or a hematologic malignancy * cognitively and emotionally able to give informed consent Exclusion Criteria: * Under age 21 * Not cognitively or emotionally able to give informed consent

Locations (1)

Scripps Translational Science Institute

La Jolla, California, United States

Outcomes

Primary Outcomes

Facilitate the development of individualized tumorgraft models for many different types of cancer.

Time frame: 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.